Letters: Musk, Ramaswamy will declare war on seniors. Developing good citizens is the key to our future. Democrats should call for Trump's resignation.

In total, The Washington Post identified 31 major campaign promises Trump pledged for his second term. Here are some of the most consequential steps Trump has said he’ll take as president.

Like most elected officials, Donald Trump recognizes that Social Security is vital to the financial well-being of our nation's retirees. But he's not oblivious to the fact that altering Social Security comes with potentially negative ramifications. While speaking at the Conservative Political Action Conference in March 2013, Trump said:

Biotech stocks have slumped 15% since Donald Trump won his second presidency. That's because Trump comes with a lot of unknowns.

Education: Trump’s proposals for K-12 schools include having parents elect school principals, cutting federal funding to any school teaching “critical race theory,” ending t

Biden's administration announced weight loss drugs Ozempic and Wegovy will be included on Medicare's list of medications subject to direct price negotiations.

House Speaker Mike Johnson said cuts to Social Security and Medicare won't be part of the legislative plan being worked out to fund President-elect Donald Trump's agenda.

Announcing the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final health policy acts.

The Biden administration’s last MA rule is a boon for insurers, though it remains to be seen how the incoming Trump administration might put its stamp on the regulation before it’s finalized this spring.

Instead, people on Medicare won’t get the two years of continued coverage for telehealth appointments and five years’ for acute hospital at home programs that were in the bill Congress nearly voted into law in December 2024.

Biden administration says popular weight loss drugs have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manufacturers

The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be targeted under legislation that’s expected save the government more than $200 billion over a decade.